Background: Sugammadex offers a good alternative to the conventional decurarisation process currently performed with cholinesterase inhibitors. Sugammadex, which was developed specifically for the aminosteroid-structured rocuronium and vecuronium neuromuscular blockers, is a modified cyclodextrin made up of 8 glucose monomers arranged in a cylindrical shape.
Methods: In this study, the goal was to investigate the efficacy of sugammadex.
Wilson's disease (WD) is characterized by progressive copper accumulation with hepatic and neurological impairment. Anesthesia and surgical practices may exacerbate WD and liver damage, and even cause life-threatening liver failure. Due to this existing liver damage, anesthetic management is important in WD cases in terms of drug choice, dose, and technique used.
View Article and Find Full Text PDF